Bank of Montreal’s Cytosorbents Corp CTSO Stock Holding History

Bank of Montreal’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,400	Closed	-$153K	–	4218
2015 Q4	$153K	Buy	+27,400	New	+$187K	﹤0.01%	2568

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's CTSO Position: Q2 2022 in Review

Bank of Montreal sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 22,524 shares — an estimated $70K sold.

Bank of Montreal first reported a position in CTSO in Q4 2015 and held it in 14 quarters. The position peaked at $1.01M in Q3 2021. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

Bank of Montreal reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
Bank of Montreal sold 22,524 Cytosorbents Corp shares in Q2 2022, an estimated $70K.
Bank of Montreal first reported a position in Cytosorbents Corp in Q4 2015 and held it in 14 quarters.
Bank of Montreal's Cytosorbents Corp position peaked at $1.01M in Q3 2021.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.